Sanofi (SNY): Today's Featured Health Care Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Sanofi ( SNY) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.3%. By the end of trading, Sanofi fell $0.53 (-1.1%) to $49.02 on heavy volume. Throughout the day, 10,012,583 shares of Sanofi exchanged hands as compared to its average daily volume of 1,424,600 shares. The stock ranged in price between $48.87-$49.40 after having opened the day at $49.34 as compared to the previous trading day's close of $49.55. Other companies within the Health Care sector that declined today were: Rexahn Pharmaceuticals ( RNN), down 16.7%, IsoRay ( ISR), down 16.4%, Prana Biotechnology ( PRAN), down 12.5% and Catalyst Pharmaceutical Partners ( CPRX), down 12.4%.

Sanofi researches, develops, manufactures, and markets healthcare products worldwide. The company operates through Pharmaceuticals, Human Vaccines, and Animal Health segments. Sanofi has a market cap of $135.3 billion and is part of the drugs industry. Shares are up 4.6% year to date as of the close of trading on Tuesday. Currently there are 4 analysts that rate Sanofi a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates Sanofi as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the positive front, Astex Pharmaceuticals ( ASTX), up 24.4%, GW Pharmaceuticals PLC ADR ( GWPH), up 17.6%, Idera Pharmaceuticals ( IDRA), up 13.1% and XOMA ( XOMA), up 10.7% , were all gainers within the health care sector with Valeant Pharmaceuticals International ( VRX) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Global Stocks Slip as 3% 10-Year Yields, Bad Tech News Unsettle Markets

Global Stocks Slip as 3% 10-Year Yields, Bad Tech News Unsettle Markets

Akorn's Stock Crashes as Germany's Fresenius Ends Takeover Amid Data Allegations

Akorn's Stock Crashes as Germany's Fresenius Ends Takeover Amid Data Allegations

Alphabet Earnings, Bond Yields Rise, Akorn Plunges - 5 Things You Must Know

Alphabet Earnings, Bond Yields Rise, Akorn Plunges - 5 Things You Must Know

Street Stats: The Mid-Term Elections May Be a Rollercoaster Ride for Investors

Street Stats: The Mid-Term Elections May Be a Rollercoaster Ride for Investors

Stocks Sputter as U.S. 10-Year Yields Test 3% Amid Commodity-Led Inflation Spike

Stocks Sputter as U.S. 10-Year Yields Test 3% Amid Commodity-Led Inflation Spike